| Integrative Group (n = 40) | Control Group (n = 40) |
Sex (Male/Female) | 21/19 | 18/22 |
Age, years | 41.33 ± 12.78 | 42.78 ± 12.34 |
Refractive error, D | −10.0 D | −10.0 D |
Duration of symptoms, months | 3.02 ± 1.58 | 3.56 ± 1.23 |
BCVA, letters | 47.10 ± 13.51 | 42.90 ± 13.18 |
CRT, μm | 370.73 ± 65.31 | 364.75 ± 69.31 |